-
Posted by
Two Blokes May 7 -
Filed in
Stock
-
2 views
SASKATOON, Saskatchewan--(BUSINESS WIRE)-- #ClinicalResearch--ZYUS Life Sciences Corporation (the “Company”) (TSX-V: ZYUS), a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, is pleased to announce that it has now completed a first tranche (the "First Tranche") of its non-brokered private placement (the "Offering") of units of the Company (each a "Unit") previously announced on May 1, 2025 for up to.
